Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)

China flag China · Delayed Price · Currency is CNY
5.14
+0.01 (0.19%)
Feb 24, 2026, 3:04 PM CST
Market Cap7.34B +1.4%
Revenue (ttm)6.85B -14.1%
Net Income374.58M +8.1%
EPS0.27 +9.4%
Shares Out1.43B
PE Ratio19.38
Forward PEn/a
Dividend0.10 (1.95%)
Ex-Dividend DateJun 23, 2025
Volume10,245,041
Average Volume15,300,089
Open5.18
Previous Close5.13
Day's Range5.11 - 5.18
52-Week Range4.62 - 6.68
Beta0.25
RSI36.79
Earnings DateApr 3, 2026

About SHE:000597

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biopharmaceuticals, and other businesses in China. It offers vitamin products, such as vitamin C, vitamin B1, vitamin B6, and L-carnitine series; anti-infection products, such as fosfomycin series, azithromycin series, amantadine series, berberine hydrochloride, chloramphenicol, and other products; and reproductive system and sex hormone products comprising carboprost suppositories, carboprost trometham... [Read more]

Sector Healthcare
Founded 1946
Employees 5,964
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000597
Full Company Profile

Financial Performance

In 2024, SHE:000597's revenue was 7.50 billion, a decrease of -8.98% compared to the previous year's 8.24 billion. Earnings were 409.85 million, an increase of 14.34%.

Financial Statements